Feasibility of home dose optimization of apomorphine sublingual film in Parkinson&#39;s disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study.

Kynmobi (apomorphine sublingual film) - Sumitomo Pharma, Aquestive, BIAL

http://www.ncbi.nlm.nih.gov/pubmed/37954918

; Alyssa Bowling; Eric Pappert; Ernest Balaguer Martinez; Fabrizio Stocchi; Jan Kassubek; Rajesh Pahwa; Stacy Wu; Stuart Isaacson; William Ondo; Yi Zhang

Nov 13, 2023